Humana Inc. (NYSE:HUM) Shares Sold by Summit Global Investments

Summit Global Investments cut its stake in Humana Inc. (NYSE:HUM) by 0.8% during the 4th quarter, Holdings Channel.com reports. The institutional investor owned 19,673 shares of the insurance provider’s stock after selling 165 shares during the period. Summit Global Investments’ holdings in Humana were worth $9,006,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Several other large investors have also recently added to or reduced their stakes in the stock. Ameriprise Financial Inc. increased its holdings in shares of Humana by 35.9% during the third quarter. Ameriprise Financial Inc. now owns 1,523,835 shares of the insurance provider’s stock valued at $741,409,000 after purchasing an additional 402,559 shares during the period. AQR Capital Management LLC increased its holdings in shares of Humana by 39.3% during the third quarter. AQR Capital Management LLC now owns 681,868 shares of the insurance provider’s stock valued at $331,743,000 after purchasing an additional 192,546 shares during the period. Quadrature Capital Ltd increased its holdings in shares of Humana by 814.5% during the third quarter. Quadrature Capital Ltd now owns 181,787 shares of the insurance provider’s stock valued at $88,448,000 after purchasing an additional 161,909 shares during the period. Adage Capital Partners GP L.L.C. increased its holdings in shares of Humana by 2,659.2% during the third quarter. Adage Capital Partners GP L.L.C. now owns 152,860 shares of the insurance provider’s stock valued at $74,369,000 after purchasing an additional 147,320 shares during the period. Finally, International Assets Investment Management LLC increased its holdings in shares of Humana by 32,648.4% during the fourth quarter. International Assets Investment Management LLC now owns 134,596 shares of the insurance provider’s stock valued at $61,619,000 after purchasing an additional 134,185 shares during the period. 92.38% of the stock is owned by institutional investors and hedge funds.

Insider Activity

In other news, Director Jorge S. Mesquita purchased 545 shares of the business’s stock in a transaction dated Tuesday, February 20th. The shares were acquired at an average price of $367.09 per share, with a total value of $200,064.05. Following the completion of the purchase, the director now directly owns 2,578 shares of the company’s stock, valued at approximately $946,358.02. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this hyperlink. 0.32% of the stock is currently owned by insiders.

Humana Price Performance

Shares of HUM stock traded up $5.84 during trading hours on Thursday, hitting $320.05. 1,145,215 shares of the company’s stock were exchanged, compared to its average volume of 1,987,243. The stock’s 50-day moving average is $325.28 and its 200-day moving average is $390.72. The company has a debt-to-equity ratio of 0.77, a current ratio of 1.67 and a quick ratio of 1.67. The stock has a market cap of $38.57 billion, a price-to-earnings ratio of 19.94, a price-to-earnings-growth ratio of 1.76 and a beta of 0.50. Humana Inc. has a 52 week low of $298.61 and a 52 week high of $541.21.

Humana (NYSE:HUM) last issued its quarterly earnings results on Wednesday, April 24th. The insurance provider reported $7.23 earnings per share (EPS) for the quarter, beating the consensus estimate of $6.12 by $1.11. Humana had a return on equity of 17.76% and a net margin of 1.82%. The business had revenue of $29.61 billion for the quarter, compared to analyst estimates of $28.52 billion. During the same quarter in the prior year, the firm posted $9.38 earnings per share. The firm’s revenue for the quarter was up 10.7% compared to the same quarter last year. As a group, research analysts forecast that Humana Inc. will post 16.18 EPS for the current year.

Humana Announces Dividend

The company also recently declared a quarterly dividend, which will be paid on Friday, July 26th. Stockholders of record on Friday, June 28th will be paid a dividend of $0.885 per share. This represents a $3.54 annualized dividend and a dividend yield of 1.11%. The ex-dividend date of this dividend is Friday, June 28th. Humana’s dividend payout ratio (DPR) is presently 22.04%.

Wall Street Analyst Weigh In

HUM has been the subject of several research reports. Wells Fargo & Company decreased their target price on Humana from $413.00 to $350.00 and set an “overweight” rating for the company in a research note on Monday, April 8th. Royal Bank of Canada decreased their target price on Humana from $415.00 to $353.00 and set an “outperform” rating for the company in a research note on Thursday, April 25th. The Goldman Sachs Group decreased their target price on Humana from $450.00 to $385.00 and set a “buy” rating for the company in a research note on Wednesday, April 3rd. Mizuho decreased their target price on Humana from $550.00 to $400.00 and set a “buy” rating for the company in a research note on Friday, January 26th. Finally, Truist Financial reiterated a “hold” rating and issued a $550.00 price target on shares of Humana in a research report on Friday, January 19th. Eleven analysts have rated the stock with a hold rating and nine have issued a buy rating to the stock. Based on data from MarketBeat.com, the company has an average rating of “Hold” and a consensus target price of $424.50.

About Humana

Humana Inc, together with its subsidiaries, provides medical and specialty insurance products in the United States. It operates through two segments, Insurance and CenterWell. The company offers medical and supplemental benefit plans to individuals. It has a contract with Centers for Medicare and Medicaid Services to administer the Limited Income Newly Eligible Transition prescription drug plan program; and contracts with various states to provide Medicaid, dual eligible, and long-term support services benefits.